OFS Capital Corp earnings beat by $0.19, revenue fell short of estimates
Karyopharm plans myelofibrosis drug filing in August
Inside Pfizer CEOs $23 billion post‑COVID bet on saving the world from cancer
Karyopharm endometrial cancer trial misses primary endpoint
Popular articles
Newsletter
Subscribe to get the latest news, offers and special announcements.


